uric acid has been researched along with Apnea, Sleep in 17 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine whether the severity of sleep-disordered breathing (SDB) was associated with increased levels of uric acid (UA), both in serum and in urine, as a marker of tissue hypoxia, in a sample of overweight and obese subjects, irrespective of indexes of adiposity." | 9.12 | Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. ( De Backer, WA; Desager, KN; Haentjens, D; Rooman, R; Schrauwen, N; Van Gaal, L; Van Hoeck, K; Verhulst, SL, 2007) |
| "Serum uric acid (UA) level is associated with the high cumulative incidence or prevalence of coronary artery disease (CAD), and hyperuricemia is considered as an independent risk marker for CAD." | 8.31 | Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease. ( Daida, H; Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 5.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "The aim of this study was to determine whether the severity of sleep-disordered breathing (SDB) was associated with increased levels of uric acid (UA), both in serum and in urine, as a marker of tissue hypoxia, in a sample of overweight and obese subjects, irrespective of indexes of adiposity." | 5.12 | Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. ( De Backer, WA; Desager, KN; Haentjens, D; Rooman, R; Schrauwen, N; Van Gaal, L; Van Hoeck, K; Verhulst, SL, 2007) |
| "Serum uric acid (UA) level is associated with the high cumulative incidence or prevalence of coronary artery disease (CAD), and hyperuricemia is considered as an independent risk marker for CAD." | 4.31 | Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease. ( Daida, H; Hiki, M; Ishiwata, S; Kasai, T; Kato, T; Kuwabara, M; Matsumoto, H; Murase, T; Murata, A; Naito, R; Nakamura, T; Sato, A; Shimizu, M; Shitara, J; Suda, S; Yatsu, S, 2023) |
| "To assess the utility of urinary uric acid excretion as a marker of nocturnal hypoxia in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) before and after the institution of nasal continuous positive airway pressure (CPAP)." | 3.70 | Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. ( Sahebjani, H, 1998) |
| "During hypoxia ATP degradation to uric acid is increased in animal models and humans." | 3.68 | Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. ( Braghiroli, A; Donner, CF; Erbetta, M; Ruga, V; Sacco, C, 1993) |
| "It was concluded that the insomnia was more prevalent than the sleep apnea." | 1.72 | Epidemiological studies of sleep disorder in educational community of Pakistani population, its major risk factors and associated diseases. ( Ahmad, S; Akmal, H; Ashfaq, M; Aslam, MW; Ditta, A; Jafar, K; Javed, T; Khan, MS; Khan, T; Rehman, TU; Sehgal, SA; Tahir, R; Umar, A; Waheed, A; Wajid, M, 2022) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 1.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "Recurrent hypoxia associated with sleep apnea-hypopnea syndrome (SAHS) leads to an increase in the degradation of adenosine triphosphatase to xanthine and, secondarily, to an increase in uric acid concentrations." | 1.33 | [Blood uric acid levels in patients with sleep-disordered breathing]. ( Capote, F; Carmona Bernal, C; García Aguilar, D; Luque Crespo, E; Romero Falcón, A; Ruiz García, A; Sánchez Armengol, A, 2006) |
| "To determine if obstructive sleep apnea (OSA) is independently associated with cardiovascular risk factors and health status in subjects with severe obesity." | 1.29 | Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. ( Grunstein, RR; Hedner, J; Sjöström, L; Stenlöf, K, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Umar, A | 1 |
| Khan, MS | 1 |
| Sehgal, SA | 1 |
| Jafar, K | 1 |
| Ahmad, S | 1 |
| Waheed, A | 1 |
| Aslam, MW | 1 |
| Wajid, M | 1 |
| Rehman, TU | 1 |
| Khan, T | 1 |
| Ditta, A | 1 |
| Akmal, H | 1 |
| Ashfaq, M | 1 |
| Javed, T | 1 |
| Tahir, R | 1 |
| Shimizu, M | 1 |
| Kasai, T | 1 |
| Naito, R | 1 |
| Sato, A | 1 |
| Ishiwata, S | 1 |
| Yatsu, S | 1 |
| Shitara, J | 1 |
| Matsumoto, H | 1 |
| Murata, A | 1 |
| Kato, T | 1 |
| Suda, S | 1 |
| Hiki, M | 1 |
| Kuwabara, M | 1 |
| Murase, T | 1 |
| Nakamura, T | 1 |
| Daida, H | 1 |
| Ando, SI | 1 |
| Sunadome, H | 1 |
| Murase, K | 1 |
| Tabara, Y | 1 |
| Matsumoto, T | 1 |
| Minami, T | 1 |
| Kanai, O | 1 |
| Nagasaki, T | 1 |
| Takahashi, N | 1 |
| Hamada, S | 1 |
| Tanizawa, K | 1 |
| Togawa, J | 1 |
| Uiji, S | 1 |
| Wakamura, T | 1 |
| Komenami, N | 1 |
| Setoh, K | 1 |
| Kawaguchi, T | 1 |
| Morita, S | 1 |
| Takahashi, Y | 1 |
| Nakayama, T | 1 |
| Hirai, T | 1 |
| Sato, S | 1 |
| Matsuda, F | 1 |
| Chin, K | 1 |
| Lai, CH | 1 |
| Huang, RJ | 1 |
| Wong, JK | 1 |
| Chang, SW | 1 |
| Chung, AH | 1 |
| Chi, YC | 1 |
| Yu, YC | 1 |
| Lee, SD | 1 |
| Ting, H | 1 |
| Van Hoorenbeeck, K | 1 |
| Franckx, H | 1 |
| Debode, P | 1 |
| Aerts, P | 1 |
| Wouters, K | 1 |
| Ramet, J | 1 |
| Van Gaal, LF | 1 |
| Desager, KN | 2 |
| De Backer, WA | 2 |
| Verhulst, SL | 2 |
| Abrams, B | 1 |
| Saito, H | 1 |
| Nishimura, M | 1 |
| Shibuya, E | 1 |
| Makita, H | 1 |
| Tsujino, I | 1 |
| Miyamoto, K | 1 |
| Kawakami, Y | 1 |
| Matsumoto, Y | 1 |
| Ruiz García, A | 1 |
| Sánchez Armengol, A | 1 |
| Luque Crespo, E | 1 |
| García Aguilar, D | 1 |
| Romero Falcón, A | 1 |
| Carmona Bernal, C | 1 |
| Capote, F | 1 |
| Van Hoeck, K | 1 |
| Schrauwen, N | 1 |
| Haentjens, D | 1 |
| Rooman, R | 1 |
| Van Gaal, L | 1 |
| Grunstein, RR | 1 |
| Stenlöf, K | 1 |
| Hedner, J | 1 |
| Sjöström, L | 1 |
| Braghiroli, A | 1 |
| Sacco, C | 1 |
| Erbetta, M | 1 |
| Ruga, V | 1 |
| Donner, CF | 1 |
| Sahebjani, H | 1 |
| Xiao, Y | 1 |
| Yin, K | 1 |
| Zheng, P | 1 |
| Kubota, O | 1 |
| Nishimura, K | 1 |
| Inoue, Y | 1 |
| Akutsu, H | 1 |
| Mizuno, H | 1 |
| McKeon, JL | 1 |
| Saunders, NA | 1 |
| Murree-Allen, K | 1 |
| Olson, LG | 1 |
| Gyulay, S | 1 |
| Dickeson, J | 1 |
| Houghton, A | 1 |
| Wlodarczyk, J | 1 |
| Hensley, MJ | 1 |
1 review available for uric acid and Apnea, Sleep
| Article | Year |
|---|---|
[Sleep apnea syndrome].
Topics: Cardiovascular Diseases; Gout; Humans; Hyperuricemia; Life Style; Sleep Apnea Syndromes; Uric Acid | 2003 |
1 trial available for uric acid and Apnea, Sleep
| Article | Year |
|---|---|
Sleep-disordered breathing and uric acid in overweight and obese children and adolescents.
Topics: Adiposity; Adolescent; Biomarkers; Child; Female; Humans; Hypoxia; Linear Models; Male; Obesity; Ove | 2007 |
15 other studies available for uric acid and Apnea, Sleep
| Article | Year |
|---|---|
Epidemiological studies of sleep disorder in educational community of Pakistani population, its major risk factors and associated diseases.
Topics: Adult; Epidemiologic Studies; Female; Headache; Humans; Male; Migraine Disorders; Pakistan; Prevalen | 2022 |
Overnight changes in uric acid, xanthine oxidoreductase and oxidative stress levels and their relationships with sleep-disordered breathing in patients with coronary artery disease.
Topics: Coronary Artery Disease; Humans; Hyperuricemia; Male; Oxidative Stress; Sleep Apnea Syndromes; Uric | 2023 |
Can we obtain a reliable marker that shows the hypoxic burden in patients with sleep disordered breathing?
Topics: Coronary Artery Disease; Humans; Hypoxia; Sleep Apnea Syndromes; Uric Acid; Xanthine Dehydrogenase | 2023 |
Associations between Sleep-Disordered Breathing and Serum Uric Acid and Their Sex Differences: The Nagahama Study.
Topics: Diabetes Mellitus; Female; Humans; Male; Oxygen; Sex Characteristics; Sleep Apnea Syndromes; Uric Ac | 2023 |
Confounded by obesity and modulated by urinary uric acid excretion, sleep-disordered breathing indirectly relates to hyperuricaemia in males: A structural equation model.
Topics: Biomarkers; Body Mass Index; Humans; Hyperuricemia; Male; Middle Aged; Obesity; Polysomnography; Sle | 2021 |
Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid.
Topics: Adenoidectomy; Adolescent; Belgium; Biomarkers; Child; Female; Follow-Up Studies; Humans; Inflammati | 2012 |
High prevalence of gout with sleep apnea.
Topics: Glomerular Filtration Rate; Gout; Humans; Hypoxia; Prevalence; Sleep Apnea Syndromes; Uric Acid | 2012 |
Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine.
Topics: Adenosine; Adult; Biomarkers; Cell Hypoxia; Humans; Male; Middle Aged; Postpoliomyelitis Syndrome; S | 2002 |
[Blood uric acid levels in patients with sleep-disordered breathing].
Topics: Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Sleep Apnea Syndr | 2006 |
Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study.
Topics: Adult; Anthropometry; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female | 1995 |
Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure.
Topics: Adult; Aged; Analysis of Variance; Circadian Rhythm; Creatinine; Female; Humans; Hypoxia; Lung Disea | 1993 |
Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure.
Topics: Creatinine; Humans; Hypoxia; Male; Middle Aged; Positive-Pressure Respiration; Prospective Studies; | 1998 |
[Significance of the changes of urinary uric acid, ANP, renin and aldosterone in sleep apnea syndrome patients].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Creatinine; Female; Humans; Male; Middle Aged; Renin; | 2000 |
[The metabolic index of nocturnal hypoxia in patients after lung resection and thoracoplasty].
Topics: Aged; Coenzymes; Creatinine; Female; Humans; Lactates; Lactic Acid; Male; Middle Aged; Pneumonectomy | 1991 |
Urinary uric acid:creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea.
Topics: 2,3-Diphosphoglycerate; Circadian Rhythm; Creatinine; Diphosphoglyceric Acids; Erythropoietin; Femal | 1990 |